Internal Medicine · Philadelphia, PA
NPI
1063671766
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
333 Cottman Ave
Philadelphia, PA, 19111
Phone (215) 728-2689
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
759 services
Medicare patients, 2024
208
Average age 73
Drug cost, 2024
$3.6M
961 prescriptions
Company payments, 2025
$149
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer S Winn was code 99215 (office e&m - established), 313 times for 141 patients. In total Jennifer S Winn billed 759 services in 11 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 313 | 141 | $109.81 | $34K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 266 | 78 | $25.02 | $6,655 |
| 99205 Office E&M - New | Facility | 50 | 50 | $141.30 | $7,065 |
| 99214 Office E&M - Established | Facility | 29 | 28 | $65.34 | $1,895 |
| 99215 Office E&M - Established | Office | 29 | 21 | $129.92 | $3,768 |
By year: 2022 $59K for 648 services; 2023 $37K for 433 services; 2024 $59K for 759 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer S Winn prescribed most often to Medicare patients was Anastrozole, with 281 prescriptions and refills. In total Jennifer S Winn wrote 961 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 281 | 764 | 95 | $7,299 |
| Ibrance Palbociclib | 135 | 136 | 17 | $2.1M |
| Letrozole Generic | 130 | 317 | 39 | $3,178 |
| Tamoxifen Citrate Generic | 63 | 141 | 17 | $2,450 |
| Exemestane Generic | 43 | 103 | 13 | $6,916 |
| Ondansetron Hcl Generic | 36 | 36 | 25 | $270 |
| Prochlorperazine Maleate Generic | 27 | 27 | 21 | $350 |
| Dexamethasone Generic | 25 | 25 | Under 11 | $384 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 18 | 22 | 17 | $189 |
| Kisqali Ribociclib Succinate | 18 | 18 | Under 11 | $242K |
| Truqap Capivasertib | 12 | 14 | Under 11 | $213K |
| Orserdu Elacestrant Hcl | 12 | 12 | Under 11 | $287K |
| Gabapentin Generic | 11 | 27 | Under 11 | $706 |
Brand drugs: 242 claims; generic drugs: 719 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer S Winn $149 ($149 in general payments such as food, travel and fees) from 5 companies. The largest payer was Daiichi Sankyo Inc. with $43.93.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.